These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22855987)

  • 1. First trial tests targeted nanoparticles in patients.
    McBride D
    ONS Connect; 2012 Jul; 27(7):25. PubMed ID: 22855987
    [No Abstract]   [Full Text] [Related]  

  • 2. Much has changed in cancer clinical trials in the past 10 years.
    Wujcik DM
    ONS Connect; 2012 Jul; 27(7):7. PubMed ID: 22855982
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials of parenteral antineoplastic agents.
    Cusack G
    J Intraven Nurs; 1998; 21(6):339-43. PubMed ID: 10392099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 1 clinical trials nursing: determining safety and side effects on the road approval.
    Lindberg D
    ONS Connect; 2012 Jul; 27(7):10-4. PubMed ID: 22855983
    [No Abstract]   [Full Text] [Related]  

  • 5. Manage side effects of cabazitaxel in patients with castrate-resistant prostate cancer.
    Becze E
    ONS Connect; 2012 Sep; 27(9):16-7. PubMed ID: 23008908
    [No Abstract]   [Full Text] [Related]  

  • 6. What skills and training do phase I clinical research nurses need?
    McAdams F
    ONS Connect; 2012 Jul; 27(7):15. PubMed ID: 22855984
    [No Abstract]   [Full Text] [Related]  

  • 7. How much time do nurses need to give chemotherapy?
    Becze E
    ONS Connect; 2011 Jan; 26(1):14-5. PubMed ID: 21355484
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy by catheter.
    Alderman C
    Nurs Stand; 1998 Apr 1-7; 12(28):25-7. PubMed ID: 9616621
    [No Abstract]   [Full Text] [Related]  

  • 9. The case of the painful port.
    Eisenberg S
    ONS Connect; 2012 Jan; 27(1):19. PubMed ID: 22355897
    [No Abstract]   [Full Text] [Related]  

  • 10. The case of the rapid rituximab regimen.
    Eisenberg S
    ONS Connect; 2012 Mar; 27(3):18. PubMed ID: 22455172
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeted therapies: aiming for the bull's-eye.
    Gaguski ME
    ONS Connect; 2007 Jul; 22(7):8-12. PubMed ID: 17694778
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnose, assess, and manage infusion reactions.
    Becze E
    ONS Connect; 2010 Jul; 25(7):12-3. PubMed ID: 20669809
    [No Abstract]   [Full Text] [Related]  

  • 13. Keys to unlock cancer: targeted therapy.
    Viele CS
    Oncol Nurs Forum; 2005 Sep; 32(5):935-40. PubMed ID: 16136192
    [No Abstract]   [Full Text] [Related]  

  • 14. So you're ready to give chemotherapy--now what?
    LeFebvre KB
    ONS Connect; 2010 Apr; 25(4):26. PubMed ID: 20437750
    [No Abstract]   [Full Text] [Related]  

  • 15. The case of anticipated alopecia.
    Eisenberg S
    ONS Connect; 2011 Jul; 26(7):17. PubMed ID: 21877440
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimitotics in cancer chemotherapy.
    Lobert S; Correia JJ
    Cancer Nurs; 1992 Feb; 15(1):22-33. PubMed ID: 1544129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common threads in cancer treatment.
    Herrington C; Wagner J; York A
    Clin J Oncol Nurs; 2009 Feb; 13(1):9-10. PubMed ID: 19193541
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing chemotherapy-related cognitive impairment.
    Becze E
    ONS Connect; 2012 Mar; 27(3):16-7. PubMed ID: 22455171
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving care for patients with nausea and vomiting.
    Heeney E
    Nurs Times; 2005 Apr 5-11; 101(14):33. PubMed ID: 15835333
    [No Abstract]   [Full Text] [Related]  

  • 20. Additional issues raised on blood returns and ports.
    Morris DJ
    Oncol Nurs Forum; 2000 Sep; 27(8):1202-3. PubMed ID: 11013901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.